Funding sources The Sheffield Hospitals’ Charitable Trust (project number 7876).
CLINICAL AND LABORATORY INVESTIGATIONS
Demonstration of autoantibodies against tyrosine hydroxylase in patients with alopecia areata
Article first published online: 17 NOV 2011
© 2011 The Authors. BJD © 2011 British Association of Dermatologists 2011
British Journal of Dermatology
Volume 165, Issue 6, pages 1236–1243, December 2011
How to Cite
Kemp, E.H., Sandhu, H.K., Weetman, A.P. and McDonagh, A.J. (2011), Demonstration of autoantibodies against tyrosine hydroxylase in patients with alopecia areata. British Journal of Dermatology, 165: 1236–1243. doi: 10.1111/j.1365-2133.2011.10597.x
Conflicts of interest None declared.
- Issue published online: 24 NOV 2011
- Article first published online: 17 NOV 2011
- Accepted manuscript online: 6 SEP 2011 06:26AM EST
- Accepted for publication 22 August 2011
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.